BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11254738)

  • 1. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis.
    Targoni OS; Baus J; Hofstetter HH; Hesse MD; Karulin AY; Boehm BO; Forsthuber TG; Lehmann PV
    J Immunol; 2001 Apr; 166(7):4757-64. PubMed ID: 11254738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
    Hofstetter HH; Shive CL; Forsthuber TG
    J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
    Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
    J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
    Denkinger CM; Denkinger M; Kort JJ; Metz C; Forsthuber TG
    J Immunol; 2003 Feb; 170(3):1274-82. PubMed ID: 12538686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
    Croxford JL; Anger HA; Miller SD
    J Immunol; 2005 Jan; 174(2):907-17. PubMed ID: 15634913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells.
    Nohara C; Akiba H; Nakajima A; Inoue A; Koh CS; Ohshima H; Yagita H; Mizuno Y; Okumura K
    J Immunol; 2001 Feb; 166(3):2108-15. PubMed ID: 11160262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y; Liu CP
    Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
    Howard LM; Miller SD
    J Immunol; 2001 Feb; 166(3):1547-53. PubMed ID: 11160195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis.
    Furtado GC; Marcondes MC; Latkowski JA; Tsai J; Wensky A; Lafaille JJ
    J Immunol; 2008 Oct; 181(7):4648-55. PubMed ID: 18802067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
    Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
    J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking of V beta 8.2-positive encephalitogenic T cells by complementarity-determining region 3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization.
    Sakuma H; Kohyama K; Jee Y; Matsumoto Y
    J Immunol; 2004 Oct; 173(7):4516-22. PubMed ID: 15383583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
    Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
    J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.